News in Brief: Baricitinib May Help Treat Lichen Planus
The oral Janus kinase (JAK) inhibitor baricitinib (Olumiant, Lilly) may help treat lichen planus, according to the first-in-human, phase 2 clinical trial. The findings, which appear in the Journal of Clinical Investigation, describe their first-in-human, phase 2 clinical trial. For the study, researchers identified unique molecular and cellular changes in the skin with lichen planus, particularly […]